One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Alto Ingredients logo
Alto Ingredients ALTO
$ 3.75 2.18%
report update icon

Quarterly report 2026-Q1
added 05-08-2026

Alto Ingredients Balance Sheet 2025-2009 | ALTO

Brief overview of Alto Ingredients's balance sheet strength

Balance sheet changes are traced across five available annual reports between 2021 and 2025.

Assets declined from $485 million to $388.8 million, or -19.8%. The contraction calls for context such as disposals, restructuring or weaker operations.

Liabilities expanded faster than the asset base, +2.7% versus -19.8%. Debt-service capacity deserves attention.

Internal capital represents 63.1% of the balance sheet, previously 71.2%. This is a strong capital position.

Net debt is $44.6 million, or 0.18x of equity. This is a conservative debt position.

Cash represents 6% of assets versus 10.4% initially, showing how the immediate liquidity reserve changed.

The balance sheet carries negative retained earnings of -$812.1 million. The figure may result from accumulated losses or an active capital return policy.

Overall assessment

Alto Ingredients's balance sheet profile is moderate. It should be considered alongside profitability, cash flow and liability maturities.

Annual Balance Sheet Alto Ingredients

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Net Debt

44.6 M 62.3 M 56.4 M 35.7 M 9.13 M 32.3 M 225 M 214 M 192 M 130 M 169 M -21.4 M 94 M 114 M 85.5 M 114 M -

Long Term Debt

63 M 92.9 M 82.1 M 68.4 M 50.4 M 71.8 M 181 M 94.1 M 221 M 188 M 204 M 34.5 M 98.4 M 117 M 93.7 M 85 M -

Long Term Debt Current

4.96 M 4.85 M 4.33 M 3.85 M 9.38 M 8.72 M 21.2 M 147 M 20 M 10.5 M 17 M - 750 K 4.03 M 750 K 38.1 M -

Total Non Current Liabilities

- - - - - - 225 M 109 M 246 M 211 M 231 M 56.1 M 118 M 130 M 104 M - -

Total Current Liabilities

59.1 M 57.8 M 65.3 M 78 M 69.6 M 86.9 M 160 M 232 M 90.7 M 78.8 M 72.9 M 25.4 M 28.2 M 12.4 M 8.98 M 47.8 M -

Total Liabilities

144 M 176 M 175 M 170 M 140 M 181 M 385 M 341 M 337 M 290 M 304 M 81.5 M 146 M 142 M 113 M 146 M -

Retained Earnings

-812 M -824 M -764 M -735 M -692 M -737 M -720 M -630 M -568 M -532 M -532 M -512 M -532 M -530 M -510 M -512 M -

Total Assets

389 M 401 M 454 M 478 M 485 M 477 M 612 M 660 M 720 M 708 M 675 M 300 M 241 M 215 M 232 M 234 M -

Cash and Cash Equivalents

23.4 M 35.5 M 30 M 36.5 M 50.6 M 48.2 M 19 M 26.6 M 49.5 M 64.3 M 51.6 M 62.1 M 5.15 M 7.59 M 8.91 M 8.74 M 17.5 M

Book Value

245 M 225 M 280 M 308 M 345 M 296 M 227 M 319 M 384 M 418 M 372 M 218 M 94.9 M 72.9 M 119 M 87.8 M -

Total Shareholders Equity

245 M 225 M 280 M 308 M 345 M 296 M 220 M 300 M 356 M 388 M 372 M 214 M 89.2 M 52.6 M 47 M -7.16 M -57.8 M

All numbers in USD currency

Quarterly Balance Sheet Alto Ingredients

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

73.1 M 101 M 118 M 111 M 92.9 M 83.3 M 91 M 84.1 M 82.1 M 75.9 M 82.1 M 83.7 M 68.4 M - 52.5 M 53.7 M 50.4 M 70.6 M 56.8 M 64.4 M 71.8 M 71.8 M 71.8 M 71.8 M 181 M 181 M 181 M 181 M 84.8 M 84.8 M 84.8 M 84.8 M 221 M 221 M 221 M 221 M 188 M 188 M 188 M 188 M 204 M 204 M 204 M 204 M 34.5 M 34.5 M 34.5 M 34.5 M 98.4 M 98.4 M 98.4 M 98.4 M 117 M 117 M 117 M 117 M 93.7 M 93.7 M 93.7 M 93.7 M

Total Liabilities

136 M 166 M 185 M 188 M 176 M 153 M 167 M 166 M 175 M 163 M 171 M 166 M 170 M - 168 M 155 M 140 M 178 M 191 M 199 M 181 M 181 M 181 M 181 M 385 M 385 M 385 M 385 M 341 M 341 M 341 M 341 M 337 M 337 M 337 M 337 M 290 M 290 M 290 M 290 M 303 M 303 M 303 M 303 M 79.9 M 81.5 M 81.5 M 81.5 M 146 M 146 M 146 M 146 M 142 M 142 M 142 M 142 M 113 M 113 M 113 M 113 M

Retained Earnings

-808 M -834 M -847 M -836 M -824 M -782 M -779 M -776 M -764 M -745 M -741 M -748 M -735 M - -673 M -695 M -692 M -728 M -724 M - -737 M -737 M -737 M -746 M -720 M -720 M -720 M -720 M -630 M -630 M -630 M -630 M -568 M -568 M -568 M -568 M -532 M -532 M -532 M -532 M -532 M -532 M -532 M -532 M -512 M -512 M -512 M -512 M -532 M -532 M -532 M -532 M -530 M -530 M -530 M -530 M -510 M -510 M -510 M -510 M

Total Assets

386 M 388 M 393 M 402 M 401 M 417 M 432 M 435 M 454 M 461 M 471 M 460 M 478 M - 531 M 498 M 485 M 483 M 499 M 501 M 477 M 477 M 477 M 477 M 612 M 612 M 612 M 612 M 660 M 660 M 660 M 660 M 720 M 720 M 720 M 720 M 708 M 708 M 708 M 708 M 675 M 675 M 675 M 675 M 298 M 300 M 300 M 300 M 241 M 241 M 241 M 241 M 215 M 215 M 215 M 215 M 232 M 232 M 232 M 232 M

Cash and Cash Equivalents

20.3 M 32.5 M 29.8 M 26.8 M 35.5 M 33.6 M 27.1 M 29.3 M 30 M 26.2 M 22.7 M 21.2 M 36.5 M 28.5 M 57.4 M 36.2 M 50.6 M 36 M 54.6 M 44.1 M 48.2 M 47.7 M 47.7 M 47.7 M 19 M 19 M 19 M 19 M 26.6 M 26.6 M 26.6 M 26.6 M 49.5 M 49.5 M 49.5 M 49.5 M 64.3 M 68.6 M 68.6 M 68.6 M 51.6 M 52.7 M 52.7 M 52.7 M 62.1 M 62.1 M 62.1 M 62.1 M 5.15 M 5.15 M 5.15 M 5.15 M 7.59 M 7.59 M 7.59 M 7.59 M 8.91 M 8.91 M 8.91 M 8.91 M

Book Value

250 M 222 M 208 M 214 M 225 M 264 M 266 M 269 M 280 M 298 M 301 M 294 M 308 M - 364 M 343 M 345 M 305 M 308 M 302 M 296 M 296 M 296 M 296 M 227 M 227 M 227 M 227 M 319 M 319 M 319 M 319 M 384 M 384 M 384 M 384 M 418 M 418 M 418 M 418 M 372 M 372 M 372 M 372 M 218 M 218 M 218 M 218 M 94.9 M 94.9 M 94.9 M 94.9 M 72.9 M 72.9 M 72.9 M 72.9 M 119 M 119 M 119 M 119 M

Total Shareholders Equity

250 M 222 M 208 M 214 M 225 M 264 M 266 M 269 M 280 M 298 M 301 M 294 M 308 M 335 M 364 M 343 M 345 M 305 M 308 M 302 M 296 M 296 M 296 M 201 M 227 M 220 M 220 M 220 M 319 M 300 M 300 M 300 M 356 M 356 M 356 M 356 M 388 M 388 M 388 M 388 M 372 M 372 M 372 M 372 M 214 M 214 M 214 M 214 M 89.2 M 89.2 M 89.2 M 89.2 M 52.6 M 52.6 M 52.6 M 52.6 M 47 M 47 M 47 M 47 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Alto Ingredients, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.